Highlights and Quick Summary
- Free Cash Flow Growth for the quarter ending October 31, 2022 was -99.17% (a 39.85% increase compared to previous quarter)
- Year-over-year quarterly Free Cash Flow Growth decreased by -93.46%
- Annual Free Cash Flow Growth for 2022 was -61.08% (a -88.08% decrease from previous year)
- Annual Free Cash Flow Growth for 2021 was -512.23% (a -863.27% decrease from previous year)
- Annual Free Cash Flow Growth for 2020 was 67.11% (a 5587.29% increase from previous year)
- Twelve month Free Cash Flow Growth ending October 31, 2022 was -50.45% (a -17.4% decrease compared to previous quarter)
- Twelve month trailing Free Cash Flow Growth decreased by -97.55% year-over-year
Trailing Free Cash Flow Growth for the last four month:
31 Oct '22 | 31 Jul '22 | 30 Apr '22 | 31 Jan '22 |
---|---|---|---|
-50.45% | -61.08% | -79.26% | -2057.55% |
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Growth of BRIACELL THERAP
Most recent Free Cash Flow Growthof BCTX including historical data for past 10 years.Interactive Chart of Free Cash Flow Growth of BRIACELL THERAP
BRIACELL THERAP Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | -99.17% | -70.91% | 13.68% | -1515.8% | -61.08% |
2021 | -2961.27% | -398.44% | -9972.79% | -18.32% | -512.23% |
2020 | 92.72% | 9.19% | 103.17% | 74.66% | 67.11% |
2019 | 27.62% | 58.17% | -68.59% | 29.01% | 1.18% |
2018 | -3.83% | -1571.22% | -40.11% | -156.84% | -169.98% |
2017 | -223.18% | 81.19% | -147.39% | -7.62% | -21.87% |
2016 | -9.6% | -15.96% | -22.11% | 39.19% | -16.92% |
2015 | -5255.36% | -1193.58% | -377.33% | -76.53% | -117.98% |
2014 | 95.58% | -142.22% | 41.21% | -332.59% | -2.7% |
2013 | 72.33% | 99.26% | 62.84% | 108.03% | 83.58% |
2012 | 56.01% | 28.24% | 74.16% | – | 5.71% |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology